Events
Jenny Speck to Speak on BARBRI Webinar
Partner Jenny Speck will speak on BARBRI’s live video CLE program, “Tax Credit Insurance for Energy Projects: PFE Exclusions, Recapture, …
November 19, 2026
November 19, 2026 • 1-minute read
Insight
Client Alerts
May 5, 2026 • 4-minute read
On April 2, 2026, the U.S. Environmental Protection Agency (“EPA”) proposed to add microplastics as a priority contaminant group to the Drinking Water Contaminant Candidate List 6 (“CCL 6”) under the Safe Drinking Water Act. The same day, the U.S. Department of Health and Human Services (HHS) launched the Systematic Targeting Of MicroPlastics (STOMP) program, committing $144 million to measure, study, and develop methods to remove microplastics and nanoplastics from the human body. EPA tied both moves directly to the Trump administration’s “Make America Healthy Again” (“MAHA”) agenda. The comment period on the draft CCL 6 closes June 5, 2026.
The CCL 6 designation does not impose any compliance obligations today. But the history of chemical regulation teaches a consistent lesson: once an agency formally signals that a substance warrants scientific attention and possible future action, the downstream effects — on rulemaking priorities, litigation narratives, plaintiff recruitment, and investor scrutiny — can arrive long before any enforceable rule does.
For years, microplastics discussions were housed in debates about recycling, packaging, and marine litter. The MAHA framework has reoriented that conversation. In The MAHA Report issued by the White House in 2025, microplastics were identified alongside PFAS (per- and polyfluoroalkyl substances) as cumulative-exposure concerns affecting children’s health. EPA’s CCL 6 listing places microplastics in the same federal pipeline through which prior drinking water standards for PFAS, arsenic, and lead ultimately traveled. The PFAS trajectory is instructive: perfluorooctanoic acid (PFOA) was first listed on CCL 3 in 2008 (finalized in 2009) and took sixteen years to become an enforceable maximum contaminant level. For microplastics, that clock started April 2, 2026. A further near-term risk: the CCL feeds the Unregulated Contaminants Monitoring Rule (UCMR), which can require public water systems to monitor for listed substances — generating national occurrence data that could accelerate both regulation and plaintiff discovery.
Microplastics litigation is still early-stage, but the trend lines are clear. Claims have generally fallen into two categories: public nuisance suits, brought primarily by state and local governments; and consumer protection suits, alleging that recycling claims, “BPA-Free” labels, or safe-disposal representations were false because products degrade into microplastics. Several cases are already pending — including suits by the City of Baltimore against major beverage companies and by California against a major plastic polymer manufacturer. No case has yet established specific human health injuries caused by microplastics, but EPA’s CCL 6 designation and HHS’s STOMP program are designed — over time — to narrow exactly that gap.
The most important near-term consequence of the April 2026 actions may not be regulatory at all. Once a federal agency formally identifies a substance as a potential public health threat — even in a research-focused posture — that designation becomes a building block in private litigation. Plaintiffs cite agency listings to establish notice, use official exposure assessments to clear admissibility thresholds for expert testimony, and invoke agency characterizations to argue that defendants failed to act when warning signs were present. Plaintiffs will cite the CCL 6 listing as evidence of recognized public health concern and will argue that companies which failed to investigate or disclose microplastics risks after April 2026 did so against a backdrop of clear federal warning. Microplastics concerns now also enjoy unusual bipartisan political durability — from environmental advocates to MAHA-aligned public health voices — reducing the likelihood this issue will recede with a change in administration.
The PFAS story is the most relevant analogue. Despite sustained challenges to causation theories, DuPont de Nemours, Inc., Chemours Company, and Corteva, Inc. settled for a combined $1.185 billion, and 3M separately committed between $10.5 and $12.5 billion to resolve claims in the same multidistrict litigation.¹That litigation gained momentum years before any enforceable federal standard existed. Talcum powder and climate change cases reinforce the same lesson: once litigation achieves scale, it becomes extraordinarily expensive and disruptive regardless of how the underlying science ultimately resolves.
Companies across the plastics and chemicals value chain should act now. Key priorities include: reviewing internal records under privilege for consistency between prior microplastics assessments and external statements; auditing trade group positions that could be used to allege coordinated concealment; developing a coordinated communications strategy across investor disclosures and product marketing; and engaging the board to document appropriate oversight. The June 5, 2026 CCL 6 comment deadline presents an immediate opportunity to engage — companies with relevant data should submit comments that inform EPA’s scientific process and help shape the evidentiary record.
Sweeping federal microplastics restrictions are not imminent. But the April 2026 actions confirm that microplastics have moved from the margins of the federal policy agenda to its center — driven by scientific concern, political momentum, and a presidential initiative with unusual bipartisan support. For companies across the plastics value chain, the window to get ahead of this issue is open, but narrowing.
¹Both settlements resolved PFAS drinking water claims in the AFFF multidistrict litigation (MDL No. 2:18-mn-2873, D.S.C.). The DuPont/Chemours/Corteva settlement was allocated per a binding MOU; the 3M settlement, with a present value of approximately $10.3 billion, is payable over 13 years. Both received final court approval in early 2024. See DuPont Form 8-K (June 2, 2023); 3M Investor Press Release (Apr. 1, 2024).
This information is provided by Vinson & Elkins LLP for educational and informational purposes only and is not intended, nor should it be construed, as legal advice.
Discover our latest:
Events
Jenny Speck to Speak on BARBRI Webinar
Partner Jenny Speck will speak on BARBRI’s live video CLE program, “Tax Credit Insurance for Energy Projects: PFE Exclusions, Recapture, …
November 19, 2026
November 19, 2026 • 1-minute read
Events
Kathy Pakenham and Adriana Wirtz to Speak at TEI’s IRS Roundtable
Partners Kathy Pakenham and Adriana Wirtz will examine how a leaner, more data-driven IRS is selecting and conducting large business …
November 19, 2026
November 19, 2026 • 1-minute read
Client Alerts
Single v Multi Contracts in Nuclear Projects: The Size of the Burden
Introduction The construction of nuclear energy projects is complex and capital-intensive, and the contracting structure can significantly affect project delivery, …
November 13, 2026
November 13, 2026 • 6-minute read
Articles
State Attorneys General Widen the Antitrust Battlefield
State attorneys general are moving to the center of antitrust enforcement, with bipartisan coalitions attacking merger settlements, information-sharing arrangements, labor-market …
November 13, 2026
November 13, 2026 • 4-minute read
Events
Jenny Speck to Speak at Lockton U.S. Energy Risk Summit
Partner Jenny Speck will speak at Lockton’s U.S. Energy Risk Summit on November 12, 2026, in Houston, Texas. The summit …
November 12, 2026
November 12, 2026 • 1-minute read
Deals & Cases
Vinson & Elkins Represents Double Eagle in Sale of Midland Basin Assets to Diamondback Energy
Vinson & Elkins represented Double Eagle IV Midco, LLC and Double Eagle V Midco, LLC (together “Double Eagle”) in entering …
November 16, 2026
November 16, 2026 • 1-minute read
Media Coverage
Vinson & Elkins Partner Joyce Adetutu joined CorpGov on the inaugural episode of Beyond the Boardroom, a new series co-produced …
November 9, 2026
November 9, 2026 • 1-minute read
Deals & Cases
Vinson & Elkins Advises Underwriters on Enterprise Products’ $1.5 Billion Senior Notes Offering
Vinson and Elkins advised the underwriters in connection with Enterprise Products Operating LLC’s (“EPO”) public offering of $1.5 billion aggregate …
November 6, 2026
November 6, 2026 • 1-minute read
Media Coverage
Aubrey Bishai Explains Responsible Vibe Coding and AI Innovation in Law.com
Vinson & Elkins Chief Innovation Officer Aubrey Bishai was featured in Law.com’s coverage of LegalTech Connect’s 2026 Knowledge Management & …
November 5, 2026
November 5, 2026 • 1-minute read
Deals & Cases
Vinson & Elkins Advises Southern Realty Trust Inc. in Merger with Sunrise Realty Trust, Inc.
Vinson & Elkins advised Southern Realty Trust Inc. in connection with its entry into a definitive merger agreement with Sunrise …
November 5, 2026
November 5, 2026 • 1-minute read
Articles
Innovation and Investment: The Next Frontier in Aerospace and Defense
Vinson & Elkins Partners Sebastian Tiller and Ben Heriaud sit down for a conversation on the firm’s Aerospace and Defense …
November 3, 2026
November 3, 2026 • 6-minute read
Articles
Law Is a Practice. So Is Business Development.
Randi Revisore, Lauren Alford, and DeAnna Englezos reflect on two years of success leading BD Lab — Vinson & Elkins’ …
July 14, 2026 • V&E+ | Values
July 14, 2026 • 7-minute read
Articles
Data Center Dealmakers: A New Era of Power and Compute
Vinson & Elkins Partners Creighton Smith and Milam Newby share the story behind a groundbreaking AI infrastructure transaction — and …
June 15, 2026 • V&E+ Ventures
June 15, 2026 • 5-minute read
Client Alerts
Mid-Level Mindset: Empowering Lawyers Through a Pivotal Career Stage
Vinson & Elkins’ inaugural Mid-Level Associate Summit brought lawyers from across the firm to Houston for three days of learning …
March 31, 2026
March 31, 2026 • 5-minute read
Client Alerts
Pro Bono at Vinson & Elkins: Lawyers Changing Lives
Pro Bono Counsel Parker Cragg reflects on a life dedicated to service, returning to Vinson & Elkins, and wisdom he has picked up along the way.
October 20, 2025 • V&E+ Values
October 20, 2025 • 6-minute read
Thoughts or questions? Send us a note, and we’ll connect you with the right person.
our People
Please note that any communication with Vinson & Elkins via e-mail through this website does not constitute or create an attorney-client relationship with V&E. Please do not send any confidential information. A conflicts-of-interest procedure must be completed by V&E prior to establishment of an attorney-client relationship. When you execute an engagement letter from V&E you will be our client, and you may then exchange information freely with a V&E attorney.
By clicking “Accept,” you agree that we may review any information you transmit to us. You recognize that our review of your information, even if it is highly confidential and even if it is transmitted in a good faith effort to retain us, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you.